Ratings Acen Corporation

Equities

ACEN

PHY1001H1024

End-of-day quote Philippines S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
3.68 PHP +7.60% Intraday chart for Acen Corporation +15.00% -15.98%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Independent Power Producers

1st Jan change Capi. Investor Rating ESG Refinitiv
-15.98% 2.35B
B-
+15.44% 40.92B
B
+12.80% 27.61B -
C
+18.51% 16.18B
B-
+26.73% 12.09B
B
+25.94% 8.94B
C+
+24.39% 6.34B
C+
+52.97% 5.68B
D-
+32.86% 5.04B
C
-7.91% 3.87B -
C
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy
  1. Stock Market
  2. Equities
  3. ACEN Stock
  4. Ratings Acen Corporation